Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gribben

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
The Lancet. Oncology|June 28, 2016
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trialLaurie H Sehn, Neil Chua, Jiri Mayer, et al.
Haematologica|October 20, 2022
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 studyPaola Ghione, M Lia Palomba, Hervé Ghesquieres, et al.
BMC Gastroenterology|June 2, 2019
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJohn A Snowden, Chris Hawkey, Daniel Hind, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Cancer Medicine|June 3, 2021
The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemiaMarcela B Mansur, Caroline L Furness, Sirintra Nakjang, et al.
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
The Journal of Clinical Investigation|March 13, 2012
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumorsRobert E White, Patrick C Rämer, Kikkeri N Naresh, et al.
Blood|January 15, 2009
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformationDerville O'Shea, Ciarán O'Riain, Manu Gupta, et al.
Haematologica|February 11, 2014
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumBirgitta Sander, Daphne de Jong, Andreas Rosenwald, et al.
Plos One|November 9, 2013
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activityNina Shah, Beatriz Martin-Antonio, Hong Yang, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|June 28, 2016
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trialLaurie H Sehn, Neil Chua, Jiri Mayer, et al.
Haematologica|October 20, 2022
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 studyPaola Ghione, M Lia Palomba, Hervé Ghesquieres, et al.
BMC Gastroenterology|June 2, 2019
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJohn A Snowden, Chris Hawkey, Daniel Hind, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Cancer Medicine|June 3, 2021
The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemiaMarcela B Mansur, Caroline L Furness, Sirintra Nakjang, et al.
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
The Journal of Clinical Investigation|March 13, 2012
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumorsRobert E White, Patrick C Rämer, Kikkeri N Naresh, et al.
Blood|January 15, 2009
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformationDerville O'Shea, Ciarán O'Riain, Manu Gupta, et al.
Haematologica|February 11, 2014
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumBirgitta Sander, Daphne de Jong, Andreas Rosenwald, et al.
Plos One|November 9, 2013
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activityNina Shah, Beatriz Martin-Antonio, Hong Yang, et al.
Pageof 11